CRISPR/Cas9-Based Protocol for Precise Genome Editing in Induced Pluripotent Stem Cells
Authors:
Open Access
- 1 January 2024
- journal article
- research article
- Published by Bio-Protocol, LLC in Bio-Protocol
- Vol. 14 (1361) , e5141
Abstract
The advent of clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-based genome editing has marked a significant advancement in genetic engineering technology. However, the editing of induced pluripotent stem cells (iPSCs) with CRISPR presents notable challenges in ensuring cell survival and achieving high editing efficiency. These challenges become even more complex when considering the specific target site. P53 activation as a result of traditional CRISPR editing can lead to apoptosis, potentially worsening cell health or even resulting in cell death. Mitigating this apoptotic response can enhance cell survival post-CRISPR editing, which will ultimately increase editing efficiency. In our study, we observed that combining p53 inhibition with pro-survival small molecules yields a homologous recombination rate of over 90% when using CRISPR in human iPSCs. This protocol significantly streamlines the editing process and reduces the time and resources necessary for creating isogenic lines.Keywords
This publication has 10 references indexed in Scilit:
- A high efficiency precision genome editing method with CRISPR in iPSCsScientific Reports, 2024
- Genome-wide association studiesNature Reviews Methods Primers, 2021
- The genome editing revolution: reviewJournal of Genetic Engineering and Biotechnology, 2020
- Highly efficient genome editing via CRISPR–Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpressionNucleic Acids Research, 2018
- p53 activation: a checkpoint for precision genome editing?Genome Medicine, 2018
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cellsNature Medicine, 2018
- A novel way to establish fertilization recommendations based on agronomic efficiency and a sustainable yield index for rice cropsScientific Reports, 2017
- Genome Engineering with Targetable NucleasesAnnual Review of Biochemistry, 2014
- Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cellsNature, 2012
- Highly efficient endogenous human gene correction using designed zinc-finger nucleasesNature, 2005